Medical ultrasonography

Global Intravascular Ultrasound Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021
General Health, Health, Medical Devices, Intravascular ultrasound, Medical ultrasonography, Compound annual growth rate

The "Intravascular Ultrasound (IVUS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Intravascular Ultrasound (IVUS) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • IVUS Catheters, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$453.6 Million by the end of the analysis period.
  • The U.S. Market is Estimated at $158 Million, While China is Forecast to Grow at 8% CAGR
    The Intravascular Ultrasound (IVUS) market in the U.S. is estimated at US$158 Million in the year 2020.
  • In the global Other Segments segment, USA, Canada, Japan, China and Europe will drive the 2.6% CAGR estimated for this segment.

Endoscopic Ultrasound Research Report 2021- Market Insights, Competitive Landscape and Market Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021
Medical devices, Health, Acoustics, Medical ultrasonography, Sound, Ultrasound, Endoscopic ultrasound

The "Endoscopic Ultrasound - Market Insights, Competitive Landscape and Market Forecast - 2026" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endoscopic Ultrasound - Market Insights, Competitive Landscape and Market Forecast - 2026" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This 'Endoscopic Ultrasound -Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of Endoscopic Ultrasound Endoscopic Ultrasound and the historical and forecasted Endoscopic Ultrasound market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.
  • Additionally, the report provides insight on the Endoscopic Ultrasound market share of the individual Endoscopic Ultrasound, current and forecasted Endoscopic Ultrasound market size from 2018 to 2026 segmented by seven major markets.
  • What will be the Endoscopic Ultrasound market growth till 2026 and what will be the resultant market size in the year 2026?

NanoVibronix Ships First Order of PainShield Plus

Retrieved on: 
Monday, July 26, 2021
Medical devices, Health, Health sciences, Health care, Health, Acoustics, Athletic training, Medical ultrasonography, Sound, Ultrasound, Physical therapy, Therapy, Pain management, Therapeutic ultrasound

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has fulfilled the first order of its next generation pain management device, PainShield Plus, and expects to recognize revenue for the sale in the third quarter of 2021.

Key Points: 
  • NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company that produces the UroShield and PainShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has fulfilled the first order of its next generation pain management device, PainShield Plus, and expects to recognize revenue for the sale in the third quarter of 2021.
  • PainShield Plus covers two times the surface area for pain therapy and is sold at a higher gross margin compared to the original PainShield MD.
  • This first shipment represents a significant milestone for our patent pending PainShield Plus, stated Brian Murphy, Chief Executive Officer of NanoVibronix, Inc. We launched the device late in 2020 to overwhelmingly positive response from orthopedic and neurological patients and healthcare providers.
  • PainShield Plus, like the original PainShield, utilizes ultrasound therapy for the treatment of pain and various soft tissue injuries either directly over joints or orthopedic hardware and without the need for messy ultrasound gels.

Portable Ultrasound Devices Market Size is Projected To Reach USD 9259.5 Million By 2026 at a CAGR of 3.2% - Valuates Reports

Retrieved on: 
Thursday, July 22, 2021
Classical mechanics, Medical ultrasonography, Acoustics, Portable ultrasound, Ultrasound, Medical imaging, Physical therapy

BANGALORE, India, July 22, 2021 /PRNewswire/ -- Portable Ultrasound Devices Market by Type - Cart-/Trolley-Based Ultrasound Equipment, Handheld Ultrasound Equipment, Application - Hospital, Clinic, Home Care, Others.

Key Points: 
  • BANGALORE, India, July 22, 2021 /PRNewswire/ -- Portable Ultrasound Devices Market by Type - Cart-/Trolley-Based Ultrasound Equipment, Handheld Ultrasound Equipment, Application - Hospital, Clinic, Home Care, Others.
  • The global Portable Ultrasound Devices Market size is projected to reach USD 9259.5 million by 2026, from USD 7408.9 million in 2019, at a CAGR of 3.2% during 2021-2026.
  • Major factors driving the growth of Portable Ultrasound Devices Market are:
    Increasing prevalence of chronic diseases that need imaging diagnosis.
  • This in turn fuels the demand for portable ultrasound devices, which is leading to the growth of the market.

Portable Ultrasound Devices Market Size is Projected To Reach USD 9259.5 Million By 2026 at a CAGR of 3.2% - Valuates Reports

Retrieved on: 
Thursday, July 22, 2021
Classical mechanics, Medical ultrasonography, Acoustics, Portable ultrasound, Ultrasound, Medical imaging, Physical therapy

BANGALORE, India, July 22, 2021 /PRNewswire/ -- Portable Ultrasound Devices Market by Type - Cart-/Trolley-Based Ultrasound Equipment, Handheld Ultrasound Equipment, Application - Hospital, Clinic, Home Care, Others.

Key Points: 
  • BANGALORE, India, July 22, 2021 /PRNewswire/ -- Portable Ultrasound Devices Market by Type - Cart-/Trolley-Based Ultrasound Equipment, Handheld Ultrasound Equipment, Application - Hospital, Clinic, Home Care, Others.
  • The global Portable Ultrasound Devices Market size is projected to reach USD 9259.5 million by 2026, from USD 7408.9 million in 2019, at a CAGR of 3.2% during 2021-2026.
  • Major factors driving the growth of Portable Ultrasound Devices Market are:
    Increasing prevalence of chronic diseases that need imaging diagnosis.
  • This in turn fuels the demand for portable ultrasound devices, which is leading to the growth of the market.

Profound Medical to Release Second Quarter 2021 Financial Results on August 4 – Conference Call to Follow

Retrieved on: 
Thursday, July 15, 2021
Neoplasms, Sonalleve MR-HIFU, Uterine fibroid, Bone metastasis, Clinical medicine, Medicine, Medical ultrasonography, Surgical oncology

Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.

Key Points: 
  • Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.
  • Profound is commercializing TULSA-PRO, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control.
  • TULSA-PRO is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (FDA).
  • Profound is also commercializing Sonalleve, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

RIVANNA Announces Record Second-Quarter Accuro Sales

Retrieved on: 
Wednesday, July 14, 2021
Medical ultrasonography, Regional anesthesia

"Currently, there are no modalities like Accuro for anesthesia providers, specifically designed to improve the efficiency of spinal needle guidance procedures."

Key Points: 
  • "Currently, there are no modalities like Accuro for anesthesia providers, specifically designed to improve the efficiency of spinal needle guidance procedures."
  • Will Mauldin, Ph.D., Co-Founder, and CEO of RIVANNA, commented, "Second-quarter Accuro sales exceeded our expectations and were due in part to our strategic distribution partnerships.
  • The product-line expansion, including Accuro 3S and Accuro XV, builds on RIVANNA's groundbreaking ultrasound-based imaging technologies.
  • Commercialization of the Accuro 3S and Accuro XV will address a billion-dollar market opportunity in pain management, neurology, oncology and emergency medicine.

Strata Imaging The Leader in New and Used Ultrasound Sales Launches New Site

Retrieved on: 
Monday, July 12, 2021
Medical imaging, Acoustics, Medical equipment, Medical ultrasound, Physical therapy, Medicine, Medical ultrasonography, Health care, Health

CARY, N.C., July 12, 2021 /PRNewswire/ -- Discover Ultrasound from Strata Imaging .

Key Points: 
  • CARY, N.C., July 12, 2021 /PRNewswire/ -- Discover Ultrasound from Strata Imaging .
  • Strata Imagingprovides complete rental, maintenance, repair, and sale of almost every type of ultrasound system and related peripherals.
  • Offering the latest in technology at a fraction of the cost via our OEM certified refurbished units, Strata Imaging helps small businesses thrive."
  • To learn more about how Strata Imaging can help you save money on your ultrasound equipment purchases, visitStata Imaging or email [email protected]
    Strata Imaging is the one-stop shop for OEM certified refurbished ultrasound machines and C-arms.

HistoSonics Announces Milestone As American Medical Association Issues Unique Category III CPT® Code For Histotripsy Of Liver

Retrieved on: 
Monday, July 12, 2021
Medical physics, Medicine, Physical sciences, Radiobiology, Applied sciences, Medical ultrasonography, High-intensity focused ultrasound, Magnetic resonance imaging, Cancer, CPT, Radiation therapy, Current Procedural Terminology

MINNEAPOLIS, July 12, 2021 /PRNewswire/ -- HistoSonics, ( www.histosonics.com ), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, is pleased to announce that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT) code for histotripsy of the liver.

Key Points: 
  • MINNEAPOLIS, July 12, 2021 /PRNewswire/ -- HistoSonics, ( www.histosonics.com ), the developer and manufacturer of a non-invasive platform and novel sonic beam therapy called histotripsy, is pleased to announce that the American Medical Association (AMA) has issued a new Current Procedural Terminology (CPT) code for histotripsy of the liver.
  • Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy tissue in the liver without incisions, ionizing radiation or heat.
  • The new CPT code will become effective on January 1, 2022, at which time providers can utilize the code when performing histotripsy procedures on patients across the United States.
  • The new Category III CPT code, 0686T Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant hepatocellular tissue, including image guidance will become effective January 1, 2022.

Insightec Announces Samsung Medical Center Is Joining Focused Ultrasound Community

Retrieved on: 
Monday, July 5, 2021
Medical imaging, Medicine, Insightec, Medical ultrasonography, High-intensity focused ultrasound, Medical technology, Neurosurgery, Health care

"Focused Ultrasound enables performing precise, minimally invasive treatments," Prof. Jung Il Lee, Professor, Department of Neurosurgery, Samsung Medical Center explains.

Key Points: 
  • "Focused Ultrasound enables performing precise, minimally invasive treatments," Prof. Jung Il Lee, Professor, Department of Neurosurgery, Samsung Medical Center explains.
  • There are 81 leading medical centers globally that have established Focused Ultrasound programs with Exablate Neuro.
  • Insightec is partnering with Huons, a manufacturer of pharmaceutical products and distributor of medical solutions, to expand Focused Ultrasound programs in the Korean market.
  • "Exablate," and "Exablate Neuro," as well as the "INSIGHTEC" logo, whether standing alone or in connection with the word " Insightec", are protected trademarks of Insightec.